Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
AstraZeneca
McKesson
Fuji
Mallinckrodt
Baxter
Citi
Colorcon
Teva

Generated: December 10, 2017

DrugPatentWatch Database Preview

METROGEL-VAGINAL Drug Profile

« Back to Dashboard

Which patents cover Metrogel-vaginal, and what generic alternatives are available?

Metrogel-vaginal is a drug marketed by Medicis and is included in one NDA.

The generic ingredient in METROGEL-VAGINAL is metronidazole. There are eighteen drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Drug patent expirations by year for METROGEL-VAGINAL

Pharmacology for METROGEL-VAGINAL

Medical Subject Heading (MeSH) Categories for METROGEL-VAGINAL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MedicisMETROGEL-VAGINALmetronidazoleGEL;VAGINAL020208-001Aug 17, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: METROGEL-VAGINAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
MedicisMETROGEL-VAGINALmetronidazoleGEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
MedicisMETROGEL-VAGINALmetronidazoleGEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
MedicisMETROGEL-VAGINALmetronidazoleGEL;VAGINAL020208-001Aug 17, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for METROGEL-VAGINAL

Drugname Dosage Strength RLD Submissiondate
metronidazoleVaginal Gel0.75%MetroGel-Vaginal9/2/2004

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
US Department of Justice
QuintilesIMS
McKesson
Deloitte
Daiichi Sankyo
Express Scripts
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot